Diaphragm Muscle Weakness Might Explain Exertional Dyspnea 15 Months after Hospitalization for COVID-19.Open Access

Regmi B; Friedrich J; Jörn B; Senol M; Giannoni A; Boentert M; Daher A; Dreher M; Spiesshoefer J

Forschungsartikel (Zeitschrift) | Peer reviewed

Zusammenfassung

Diaphragm muscle weakness was present 15 months after hospitalization for COVID-19 even in patients who did not require mechanical ventilation, and this weakness was associated with dyspnea on exertion. The current study, therefore, identifies diaphragm muscle weakness as a correlate for persistent dyspnea in patients after COVID-19 in whom lung and cardiac function are normal. Clinical trial registered with www.clinicaltrials.gov (NCT04854863).

Details zur Publikation

FachzeitschriftAmerican Journal of Respiratory and Critical Care Medicine
Jahrgang / Bandnr. / Volume207
Ausgabe / Heftnr. / Issue8
Seitenbereich1012-1021
StatusVeröffentlicht
Veröffentlichungsjahr2023 (15.04.2023)
Sprache, in der die Publikation verfasst istEnglisch
DOI10.1164/rccm.202206-1243OC
Link zum Volltexthttps://pmc.ncbi.nlm.nih.gov/articles/PMC10112448/
StichwörterAged; Female; Humans; Middle Aged; COVID-19; Diaphragm; Dyspnea; Hospitalization; Muscle Weakness; Muscular Diseases; Thoracic Diseases

Autor*innen der Universität Münster

Boentert, Matthias
Klinik für Neurologie mit Institut für Translationale Neurologie